$277 Million is the total value of Cavalier Investments, LLC's 95 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XLK | New | Technology Select Sector SPDR Fundtechnology | $8,503,000 | – | 71,587 | +100.0% | 3.07% | – |
XLI | New | Industrial Select Sector SPDR Fundsbi int-inds | $6,968,000 | – | 84,117 | +100.0% | 2.52% | – |
XAR | New | SPDR S&P AEROSPACEaerospace def | $3,687,000 | – | 40,219 | +100.0% | 1.33% | – |
XHS | New | SPDR S&P HEALTH CARE ETFhlth care svcs | $2,687,000 | – | 30,602 | +100.0% | 0.97% | – |
VNQ | New | Vanguard REIT ETFreal estate etf | $1,523,000 | – | 19,000 | +100.0% | 0.55% | – |
WM | New | Waste Management | $706,000 | – | 4,404 | +100.0% | 0.26% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TECHNOLOGY SELECT SECTOR SPDR FUND | 31 | Q3 2023 | 11.7% |
SELECT SECTOR SPDR TR | 28 | Q3 2023 | 9.1% |
Standard & Poor's Depositary Receipts | 28 | Q3 2023 | 8.2% |
ISHARES TRUST | 28 | Q1 2023 | 3.0% |
SELECT SECTOR SPDR TR | 26 | Q3 2023 | 8.8% |
ISHARES U.S. MEDICAL DEVICES ETF | 26 | Q3 2023 | 4.7% |
ISHARES TRUST | 25 | Q1 2023 | 8.8% |
SELECT SECTOR SPDR TR | 23 | Q3 2023 | 9.1% |
ISHARES TRUST | 22 | Q1 2023 | 2.3% |
SELECT SECTOR SPDR TR | 21 | Q2 2023 | 17.1% |
View Cavalier Investments, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-26 |
13F-HR | 2024-02-13 |
13F-HR | 2023-10-23 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-10 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-04 |
13F-HR | 2022-05-04 |
13F-HR | 2022-02-02 |
View Cavalier Investments, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.